[On the influence of oral gestagens on the increased excretion of neutral 17-ketosteroids and 17-hydroxycorticosteroids in anovulatory sexually mature women].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008656:Mestranol / Q000627:therapeutic use; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use; D011276:Pregnanediol / Q000627:therapeutic use; D011278:Pregnanes / Q000627:therapeutic use*; D013607:Tablets
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D011278:Pregnanes; D013607:Tablets; D004997:Ethinyl Estradiol; D008656:Mestranol; D011276:Pregnanediol; D009640:Norethindrone
Uber den Einfluss oraler Gestagene auf die erhöhte Ausscheidung der neutralen 17-Keto-steroide und 17-Hydroxycorticosteroide anovulatorischer geschlechtsreifer Frauen.